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Abstract
Drug misuse and hepatitis C are known to be endemic in Irish prisons. Using a grounded theory approach, this qualitative study sought
to examine prisoners’ views of drug injecting practices and harm reduction interventions in Dublin prisons. Thirty-one male prisoners were
interviewed (16 injecting drug users and 15 non-injectors). Two themes relevant to drug use practices emerged. Respondents described increased
health risks related to injecting drug use during detention and associated with a prison environment. These included: the low availability of heroin
which encouraged a shift from smoking to injecting; the scarcity of injecting equipment which fostered sharing networks far wider than outside
prison; inadequate injecting equipment cleaning practices; and the rent of needles and syringes in exchange for the drugs. Both non-injectors and
injectors interviewed supported harm reduction interventions in prison and felt that the range of drug services available in prison should mirror
those currently available in the community, although half opposed or had reservations about syringe exchange in prison. Prisoners’ viewed
their time in prison as an opportunity to address substance misuse related problems; health professionals should not miss this opportunity.
© 2003 Elsevier B.V. All rights reserved.
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Introduction
In 1994, Turnbull et al. published a study that examined
drug use in English prisons (Turnbull, Stimson, & Stillwell,
1994). They found that cannabis and heroin were the most
commonly used drugs in English prisons, with cannabis
used daily and heroin weekly. They reported that drugs
were brought into prison via a variety of outside contacts
(visitors, court appearances and temporary release) and
that drugs were shared with other prison inmates. This ar-
rangement was mainly reciprocal or occasionally altruistic
(giving another prisoner some heroin to alleviate symptoms
of withdrawal). They found that episodes of violence were
associated with drug use in prison. They reported less fre-
quent injecting in prison than outside prison, but higher lev-
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els of sharing injecting equipment among larger cohorts of
individuals. This latter finding is in keeping with other stud-
ies (Allwright et al., 2000; Bird, Gore, Cameron, Ross, &
Goldberg, 1995; Bird, Gore, Jolliffe, & Burns, 1992; Carvell
& Hart, 1990; Dolan, Hall, & Wodak, 1996; Gore et al.,
1995; Gore, Bird, Burns, Ross, & Goldberg, 1997; Long
et al., 2001; Malliori et al., 1998; Turnbull, Dolan, &
Stimson, 1991). Turnbull et al. also reported that needles
and syringes were rarely if ever disposed of in prison but
were passed on to other inmates on release (Turnbull et al.,
1994). Several studies have reported actual or probable
transmission of blood-borne viruses in the prison environ-
ment (Crofts et al., 1995; Haber et al., 1999; Hutchinson
et al., 1998; Taylor et al., 1995).
In Ireland, in 1998 and 1999, Allwright et al. and Long
et al. conducted national surveys to estimate the level of in-
fection with blood-borne viruses (hepatitis B, hepatitis C and
HIV) in the Irish prison population and to identify risk fac-
tors for infection (Allwright et al., 2000; Long et al., 2001).
Hepatitis C infection was shown to be endemic in Irish pris-
ons: prevalence rates among prison inmates were 37% over-
all and 81% in injecting drug users (Allwright et al., 2000).
The most important risk factor for infection was injecting
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drug use. These surveys showed that injectors were more
likely to share injecting equipment inside prison than out-
side prison, and found that sharing needles inside prison was
associated with an increased risk of hepatitis C (Allwright
et al., 2000; Long et al., 2001). These studies also found
that as time spent in prison increased, so did the risk of
testing positive for hepatitis C. The qualitative study pre-
sented here sought to explain the risk factors identified in
these two quantitative surveys through exploring prisoners’
perceptions on whether and how injecting practices differed
inside and outside prison.
An additional reason for this study was that the Irish
Government Department of Justice, Equality and Law Re-
form review of prison-based drug services in Ireland had
consulted all stakeholders, except prisoners (Irish Prison
Service, 2000). In order to remedy this oversight, this study
sought to document prisoners’ suggestions (both injectors
and non-injectors) for harm reduction interventions so as to
reduce the risk of viral infection in Irish prisons.
Methods
The study employed qualitative research methods using
a grounded theory approach to explore respondents’ lived
experiences of injecting drug use and heroin addiction
in prison (Polit & Hungler, 1999; Streubert Speziale &
Carpenter, 2003). The study examined injecting drug use
in the prison environment and the prison service’s potential
for response by considering the perspectives of both injector
and non-injector prisoners (person triangulation) (Denzin,
1989). In line with a grounded theory approach, the in-
terviewees were considered expert witnesses in relation to
injecting drug use and prison life.
Sample sites
The prisons were selected from the eastern region of Ire-
land as injecting drug use is concentrated in this region. The
Director of Prison Medical Service suggested that the re-
search team use prisons other than those in the Mountjoy
Complex because several other research studies had been
conducted with prisoners detained in this prison complex,
and it was important to consider the views of prisoners de-
tained elsewhere. Wheatfield Place of Detention, Dublin and
Portlaoise Prison, Co. Laois (45 miles from Dublin) were
selected as it was believed that these prisons would pro-
vide an adequate number of injectors who injected while
in prison as well as non-injectors who had observed in-
jecting. The majority of prisoners in Wheatfield Prison and
Portlaoise Prison would have been committed initially to
Mountjoy Male Prison or St. Patrick’s Institution. Conduct-
ing the study at two prison sites ensured an adequate num-
ber of non-injectors as well as enabled the documentation of
prisoners’ perspectives at different sites (place triangulation)
(Denzin, 1989). The study was conducted independently of
the Department of Justice, Equality and Law Reform and
the individual prison authorities, although their permission
and co-operation was sought and provided.
Participants
A purposive sampling method was employed. Two types
of respondents were sought, injectors and non-injectors.
Prisoners who had never injected illicit drugs were asked
if they had observed injecting drug use in prison and if
so, to describe what they had observed. Approximately 30
respondents were deemed necessary to achieve maximum
saturation, but 31 (16 injectors and 15 non-injectors) were
interviewed. The respondents were detained in Portlaoise
Prison (15) and Wheatfield Place of Detention (16). All
respondents were over 18 years old, had spent time in the
Mountjoy Complex of prisons (where there is a high preva-
lence of heroin use), and were willing to converse and capa-
ble of talking about drug using experiences. Sex offenders
and political or high security prisoners were excluded as
they were separated from the general prison population
and were deemed unlikely to have extensive experience of
injecting drug use while in prison.
Data collection
Data were collected through in-depth interviews using a
semi-structured questionnaire and an interview topic guide.
The use of the topic guide (rather than a structured ques-
tionnaire) allowed the interviews to include a wider range
of participant experiences and views. Data collected in this
way seeks to describe a concrete lived experience (Poland,
1999).
The interviews were held in a quiet room (classroom in
Portlaoise and visitors’ room in Wheatfield) with an assigned
prison officer waited outside the closed door, and took place
over a period of 5 weeks in 2000. The first four interviews
were undertaken as pilot interviews. When undertaking in-
terviews, the purpose of the study and methods were ex-
plained (including the taping of the interview) and the volun-
tary nature of the study was stressed. The interviewer (J.L.)
introduced herself as a health professional, independent of
the prison authorities. All interviewees gave signed consent
to participate. Field notes were kept, which helped to place
the interviews in the context of their surroundings and al-
lowed the interviewer to record new issues to be explored
in future interviews.
All respondents were asked 12 closed questions pertaining
to socio-demographic characteristics, prison history, illicit
drug use and alcohol use. The respondents who had a history
of injecting drug use were then asked about drug use outside
prison, drug use inside prison and the dangers of injecting
drug use. The topics differed slightly for non-injecting re-
spondents: they were asked about their personal experience
of drug use outside and inside prison, observations on in-
jecting drug use in prison and fears associated with inject-
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ing drug use. All respondents were asked “what action is
required by the prison authorities to deal with drug misuse
in prison?”.
Data analysis
Interview tapes were transcribed verbatim. Written notes
supplemented what was said during the interviews and
Silverman’s transcription symbols were employed to en-
sure consistency in transcription style (Poland, 1999). The
interviewer (J.L.) listened to each tape three or four times,
initially (during the interview period) to identify new issues
and later to ensure that the transcripts accurately reflected
the tapes.
Six transcripts (three each from injectors and non-injectors)
were coded by two team members (J.L. and C.B.). Where
codes differed, these were discussed and an agreed com-
promise adopted. The 31 transcripts were entered into
‘Ethnograph’ (Seidel, 1998) and coded by J.L. An audit
trail (Appleton, 1995) was kept, showing how codes led to
categories and categories formed the themes. Five overall
categories emerged and two themes were identified from
these categories. Participants’ narratives were used to illus-
trate these themes (Koch, 1994). Negative cases (Mariano,
1995) were identified and acknowledged, but did not con-
tradict the main findings.
Ethical approval and confidentiality
The study had ethical approval from the Trinity College
Public Health Ethics Committee. Confidentiality was as-
sured and no prisoners’ names were recorded. Following
each interview, reference to the respondents’ name on the
taped interview was removed and replaced with a number.
The tapes were cleaned once the interviews had been tran-
scribed and verified.
Findings
Participant characteristics
All 31 of the respondents were male. The median age
(range) of the respondents was 26 (18–37) years. Two
thirds (21/31) of the participants said that they normally
resided in Dublin. Only two respondents had completed
second level education. All of the prisoners interviewed
had been sentenced. Four (13%) of the 31 respondents
reported that this was their first imprisonment. Over two
thirds (21/31) of the participants said that they had spent at
least 3 of the last 10 years in prison. Three quarters (23/31)
of the prisoners described their crime as drug or alcohol
related.
Most respondents started to use illicit drugs when they
were between 13 and 15 years old, and they reported a
similar pattern of progression in drug use. All of the re-
spondents reported taking illicit drugs at some time in
their life. Three respondents reported having used one il-
licit drug only (cannabis). Sixteen participants reported
that they used heroin more frequently than other drugs,
while eight reported using cannabis more frequently. Of
the remaining seven respondents, three had taken cocaine
more frequently than other drugs and the others had used
ecstasy. Three quarters of the respondents said that they
had taken heroin (24/31) or ecstasy (24/31) at least once.
Five (16%) respondents stated that they were dependant
on alcohol prior to imprisonment. Five (16%) participants
said that they were using heroin at the time of the inter-
view.
Key themes
Two themes relevant to drug use emerged from the anal-
ysis of interview transcripts; first, injectors take risks during
detention that they would not take outside prison; second,
prisoners want and will support programmes to address drug
misuse. We explore these findings below.
Injectors take risks during detention that they would not
take outside prison
Context
Eleven respondents stated that hash (cannabis) and heroin
were available in prison. One respondent stated that cocaine
was also available while another contradicted this statement.
The respondents said that drugs (including heroin) were
more easily available in the Dublin prisons (Mountjoy Male
Prison, St. Patrick’s Institution, and Wheatfield Place of De-
tention) than in Portlaoise Prison. According to the respon-
dents, availability was highest in Mountjoy Male Prison and
the ‘drug situation’ was ‘out of control’ in this prison. Re-
spondents used drugs to escape from the reality of their life,
to be part of a particular group of people and to relieve bore-
dom in prison:
I think a lot of heroin use begins in the prisons. Once the
gates close behind you and you have no escape, people
look to escape through heroin. (NONA1)
Is it very difficult to be off heroin? (J.L.)
It would be, it was when I was in the last prison ((Moun-
tjoy Male)) but, down here ((Portlaoise Prison)) it’s not,
no. (IDUA3)
Why was it difficult in the last prison? (J.L.)
Because there’s too much of it around. Thinking about it
all the time, people going around stoned. (IDUA3)
At the time of the study, inadequate detoxification on entry
to Mountjoy Male Prison led to unnecessary suffering in this
prison: prisoners addicted to heroin were offered a 2-week
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methadone detoxification programme using an (inadequate)
decreasing dose of methadone from 25 to 5 mg.
How would withdrawals have differed in prison from the
outside? (J.L.)
Em, it didn’t differ at all, you’re going through the same
thing. The only . . . thing about being in jail is when you’re
locked behind a cell and you just can’t open that door and
go walking when things is getting on top of you, that’d be
the main difference from here to the outside . . . . (IDUB1)
The uptake of the short detoxification course indicated that
prisoners were willing to substitute heroin with methadone;
12 injectors and one smoker interviewed said that they had
availed of this short detoxification course known as a ‘crash
course’; but most had used heroin throughout, due to an
inadequate methadone dose.
Low availability of heroin encouraged the change from
smoking to injecting
Overall the low availability of heroin in prison influ-
enced the change from smoking to injecting. According to
the respondents, a small but significant (3) number of them
started to inject in prison. Some of the respondents who
smoked heroin were asked if they had any problem satis-
fying their heroin habit in prison. It was clear from the re-
spondents that they were not forced to inject rather than
smoke heroin in prison, but when supplies were low, a
group would agree that if they injected, then lower quanti-
ties of heroin would be required to experience a ‘buzz’. This
is generally how the decision to inject rather than smoke
was made.
And why did . . . why did you start injecting in here? (J.L.)
. . . I was only in ((prison)) off the streets . . . at the time
and I had a couple of, em, mates here . . . and they were
getting heroin in and they were more or less saying “well
we haven’t really got it to give it to you to smoke, but
there’s a turn on ((heroin taken by injection)) there if you
want it”, you know what I mean? Like “you can have a
turn on, but there’s not enough there for you to have a
smoke the way you smoke the stuff” . . . . (IDUA10)
. . . I started using ((injecting)) heroin again, like intra-
venously, only for about 3 or 4 months and then I went
back smoking, . . . was only using it intravenously ’cos I
was in prison . . . (IDUA13)
If there’s a lot of heroin there to take, it’s okay for ev-
erybody to smoke right, and they have a little habit ((ad-
diction)) in prison. Then there comes a day when there’s
only enough for three people and they say look if we all
have a turn ((injection)) and then we’ll all still get a buzz
out of it and that’s how people end up going from smok-
ing to injecting. It’s because there’s not enough there and
they feel that their need to get that bit of heroin like, even
if they have to use ((inject)) it. (NONB2)
Those who own a needle and syringe rent them to others
as a means of acquiring drugs to maintain a habit
Injectors reported that the methods used to fund drug mis-
use outside prison (robbery and selling drugs) differed from
the methods used in prison (bartering and owning injecting
equipment). As the following extracts illustrate when out-
side prison:
. . . I started dealing in heroin and . . . 3 months it was,
when there wasn’t much around, and I was making over
£1,000 a day, but I had no money to show for it, I was
using it all ((to fund my heroin habit)). (IDUA5)
Using the last two or three year. Gone robbing and all that
to feed me habit like, so I got locked up, and, er, that’s it
really. (IDUB8)
I used to sell it and all, you know?, so I was doing well
and all, I had money and all but then I started getting into
cocaine and all, you know? I lost like . . . I had no money
or nothing and er, . . . every morning waking up dying
sick, saying “ah here I am going to have to rob to get any
((money)), where am I going to get money today?” . . .
(IDUB9)
Whereas injector respondents said that if an injector
owned a syringe and needle in prison he could rent it to
other injectors in return for heroin, and thereby, maintain
his habit:
You’d, yeah, you’d, er, there’s be a bit of bartering going
down here. You’d give someone a bit and the day you’d
have nothing you’d be depending on them . . . . (IDUA13)
Em, it’s just like the lads on the landin’ like. Like they’re
good . . . they’re sort of good friends of mine like. I get
on well with them like (NONB15)
If you own a syringe in here you can feed a habit, you
can keep your habit going ’cos every day of the week
someone’s going to come to you with heroin and say
“listen, I have gear, do you want a bit of it for a lend of
your syringe” and that’s the way things work, you know?
(IDUB1)
Scarcity of injecting equipment meant that sharing circles
were far wider than outside prison
A number of injectors said that they had taken risks in re-
lation to sharing during detention that they would not take
outside prison. Almost all injectors said that outside prison
they obtained their injecting equipment from a needle ex-
change facility and one-third reported that when outside
prison they had never shared injecting equipment. Most re-
spondents who shared injecting equipment outside prison
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did so with one or two other people only, while two had
shared indiscriminately:
You know?, so I always, from day one, . . . had my clean
needles an’ all, you know? I never used after anybody.
(IDUA2)
. . . I probably always inject with me girlfriend, you know
like? . . . (IDUB9)
Yeah, I share with my brother . . . and girlfriend.
(IDUA10)
On the other hand, when respondents were imprisoned,
they consistently reported an increase in the number of times
that they had shared injecting equipment as well as the num-
ber of people with whom they shared:
Yeah well, ah yeah, well it’s obvious the risk factors are an
awful lot higher for the simple reason is, there’s only a cer-
tain amount of needles and syringes in prison. (IDUA11)
In prison . . . , I’m not lying you want to see the state of
the works ((syringes and needles)) . . . . The spikes ((nee-
dles)) . . . do be bent . . . about six people like using them.
There’s about 30 people on a landing and I’d say be-
tween the three landings there’s only about four or five
syringes . . . and half of them on the landing would be us-
ing the syringes, you know?, very dangerous (IDUB9)
There’d be people I’d be wary of sharing with, but there’d
be days ((in prison)) when things would be that bad that
you’d have to use it ’cos you’d be that sick ((suffering
from withdrawals)), that craving, you know? Well, you’d
know people who’d have one ((syringe and needle)) and
you’d approach them and ask them for a lend of it. Now
you’d know yourself that it’s probably after being around
the prison for years, but you’d just say ah I’ll put a bag
on it and steep the spike in bleach for half an hour and
it’ll be alright. (IDUB7)
You mentioned put a bag on it. Put a bag on what? (J.L.)
On the barrel ((syringe)). On the plunger bit of the barrel
put a bag ((piece of a plastic carrier bag)) onto it and it
stops it from whatever, you know? just to be safe, ’cos if
the virus was on the barrel, put a bag over it. (IDUB7)
Cleaning practices for injecting equipment were inadequate
According to the respondents, shared injecting equipment
was inadequately cleaned and sterilised. Six respondents
washed the equipment in cold water only, a further five used
diluted bleach to wash it and a small number steeped the
equipment in bleach after washing it. Four respondents said
that they put a clean plastic bag over the plunger (within
the syringe) to protect themselves from others’ blood. Two
respondents said that after cleaning the needle and syringe
they left it to dry in the air for a few hours because they be-
lieved that this prevented them from acquiring one or more
of the blood-borne viruses.
How would you clean them ((syringes and needles))?
(J.L.)
Just water, just . . . give them a good rinse. (IDUA13)
And nowadays would you do anything differently, if
you’re going to inject? (J.L.)
Oh, er, like I’d put a bit of bleach on it or something, but,
em, it wouldn’t make any difference, no, I’d still just, I’d
rinse it out before I’d do anything. . . . Er, I wouldn’t use
straight after anybody, even rinsing it, it’s all to put me
mind at ease, you what I mean? . . . Just giving it a good
clean out, put a clean bag ((piece of a plastic carrier bag))
on it. . . . I wouldn’t, . . . use directly and I know like even
a dirty needle and all that, but, er, I always managed to
clean it out or to wait an hour or two before I used it . . .
(IDUA13)
Now they’re not being cleaned proper for one, I know
there’s bleach and all down the jacks, you can bleach
them, but they’re only, they’re putting plastic ((piece of a
plastic carrier bag)) over, . . . the plunger. They’re putting
plastic over it. You know?, they’re not cleaning the plastic
out proper either. They clean it, you know?, if there’s no
more plastic left, they turn it around and stick it back
in. Now . . . it’s obvious . . . there’s still going to be some
traces of blood, you know what I mean?, and they’re not
ever giving it any time to, er, how do you say?, die down.
It’s supposed to die after so long, isn’t it?, outside the
body. (IDUA11)
Non-injectors reported observations were consistent with
injectors reported practices
The non-injectors in prison said that they knew which
prisoners were current injecting drug users. Almost all
non-injectors had observed injecting drug use in prison, and
their reported observations of injecting were consistent with
those reported by respondents who had injected in prison:
They’re the “Desperate Dans” they’re called. As in when
someone goes on a visit ((relative or friend calls to visit
them in prison)) an’ they know he’s gonna get somethin’
there’s about bleedin’ fifteen of them waitin’ for your
man to come back an’ they’re all huddled kinda in a
corner. They just stand out. Everybody knows, you know?
(NONB13)
. . . out in the yard and there’s, er, ten or twelve of them
sittin’ in circles, ganged up together and they’ve got two
syringes and they’re, they’ve got a milk carton ((for the
water to clean the needle and syringe)) and they’ve water
and probably a jam tray ((used to cook the heroin)) or
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somethin’ and they’re shootin’ heroin on the jam tray and
they’re just dippin’ it ((needle)) in the water and that’s
it, that’s how they’re cleanin’ it and I mean you’d know
straight away when you’d see the circle like. You’d know
they’re all over there bangin’ up ((injecting)) like, you
know? (NONB11)
Prisoners want and will support programmes to address
drug misuse
All respondents were asked “what action is required by
the prison authorities to deal with drug use in prison?” Re-
spondents suggested a number of interventions including the
organisation of daily activities in prison, drug awareness pro-
grammes, individual counselling sessions and harm reduc-
tion services. Non-injectors were in general understanding
of the needs of injectors and both non-injectors and injectors
supported positive action by prison authorities to address in-
jecting drug use in prison. Both injectors and non-injectors
want the range of drug services in prison to mirror the range
currently available in the community but recognise that these
will require strict supervision.
Regular routine
Many respondents said that a regular routine including a
high quality education programme, a part-time occupation
and a variety of recreation facilities had helped them tackle
drug misuse in prison:
I use the gym. I use the school now and again and I’m
working in the prison itself. . . . So, I’m keeping myself
active alright. I’m not just sitting around bored all day. It
helps. (IDUB10)
I didn’t take physeptone and for the first 6 months that I
spent in Mountjoy, before I came down here to Portloaise,
I didn’t touch anything ((any drugs)). I started doing the
gym and all. And, er, I came down here then and that’s
when I, when I took up a lot of, er, education and all, you
know? And I think that’s very important . . . (IDUA5)
I go to school, do the gym every now and again, but for
others there’s, em, like a lot of spare time on their hands
and that’s why you can’t have too much time . . . You have
to be doing something to keep busy otherwise you just go
back into that slump of drugs, drugs, drugs. (NONW12)
Counselling and support
Prisoners appreciate information sessions on drugs,
and according to respondents, individual counselling for
self-selected prisoners was useful.
. . . I believe like to give up drugs it’s down to the person,
they have to decide that, it’s really them like. 99% of
people that go into, that go for counselling . . . go in for
therapy or whatever they don’t go in for the right reasons
like, they’re going in because so and so says it’s the best
thing to do or ’cos they have court ((to reduce the possible
sentence)) or because they have charges or it’s that they’re
looking for somewhere to lay the blame (NONB2)
A small number of respondents who had attended indi-
vidual counselling in prison said that counselling (two to
three times per week) had helped them to solve problems
that they were experiencing.
Yeah, I get counselling here . . . Well, if you have a prob-
lem like they work it out with you, do you know what I
mean? Like, if I have a problem like, which I had, I had
plenty of problems, everybody has problems. I mean you
just, you talk to him about it you know and try to work
a way around it. You focus in on that for today like just
whatever you know. It was all right that way. (IDUB5)
Em, well for starters the person, the Welfare Officer him-
self he was down to earth, em, he was the type of person
that . . . if he thought you were giving him bullshit, lying
to him or anything he’d come out and say “well listen I
think your lying to me” . . . Some people you can pawn
off . . . you can say to them well this is what’s wrong with
this, that and the other but you’re getting away from the
point altogether. This fellow used to sit down and you’d
tell him, you’d say something to him, if he thought you
were fucking him around or anything he’d come up to you
and say listen you may leave and come back to me dur-
ing the week when you want to talk to me honestly what-
ever, so he was just genuine and I could see he wanted
to help. It helps to know that someone wants to help, do
you know what I mean? (IDUW1)
The majority of respondents said that they would value
individual counselling.
Yeah, I think it could be useful, yeah. Well it would prob-
ably put it in your mind to stay away from drugs you
know when you get out. A few of my friends went to the
detox places and stayed there you know and just came out
clean. They’re all right, all right, jobs and all. (NONW16)
A (further) small number of respondents had tried coun-
selling but found that they could not talk about personal
issues to a complete stranger. Two prisoners said that they
would attend counselling if it would help them achieve a
favourable review of the duration of their sentence.
Findings suggested that support groups in prison are in-
effective if they are misused. For example, respondents re-
ported that a session supported by Narcotics Anonymous is
held in Wheatfield Place of Detention every month. None
of the prisoners who attended these sessions reported that it
had helped them to stay off drugs. It would appear that at-
tendance at these sessions is not screened and often persons
under the influence of drugs attend and disrupt proceedings.
A more serious problem noted was that a small number of
inmates requested counselling and were referred (inappro-
priately) by the prison management and/or other staff to
these support sessions instead.
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And have you sought any help? Have you talked to any-
body about that ((recent bereavement))? (J.L.)
Em, the only person I’ve talked to about it is the nun in
here an’, er, I talked to the governor as well like . . . And
I asked the governor like was there any chance of getting
help and he just told me for to go to the . . . NA ((Narcotics
Anonymous)) meetings and like I went to a few of them,
but there’s no point going to them because like the lads
what goes to them they’d be stoned out of their heads like
and they just go up for the laugh like . . . (NONB15)
And, have you gone to, em, to see the Probation and
Welfare Officer or anybody else? (J.L.)
I seen the Welfare Officer yeah. (NONB15)
And what have they said? (J.L.)
Em, she just told me for to go to the NA as well an’ I
told her I said “there’s no point like goin’ to the NA” I
said “because there’s lads up there an’ they’re stoned out
of their head” I said. (NONB15)
Drug free units
Several respondents (both injectors and non-injectors)
said that they would welcome an increased number of regu-
lated drug free units in Irish prisons. Portlaoise Prison was
regarded as a drug free prison but it has a limited number
of places that were generally reserved for prisoners who
are deemed suitable for a 50% reduction in their length of
sentence:
((Portlaoise Prison)) It’s a, er, a drug, a drug free prison,
supposed to be in any case. The part that I’m in anyway,
there’s no syringes in it. (IDUA3)
At the time of the interviews a drug free unit had just
opened in St. Patrick’s Institution for young offenders. Ac-
cording to the respondents, Mountjoy’s Training Unit was a
designated drug free area but places were limited. Respon-
dents suggested that both Wheatfield and Mountjoy Male
Prison should introduce large scale voluntary drug free units.
Respondents reported that living in an environment where
drugs were used was very difficult, if they wanted to stay
off drugs.
Have separate units for people who don’t use drugs, em,
from my own experience, I’ve made a decision to be off
drugs and I have been off drugs for, em, the last 17 months
and er, I feel much better because of it but I would prefer
to be away from drugs altogether because there’s always
that temptation even just to have a joint or something like
that, em, but if it was a totally drug-free unit or something
and if it was strictly kept that way I think that would
help . . . but I think more drug testing needs to be done in
prisons, em, even for the likes of hash or whatever, . . .
(NONB4)
Yeah, I’ve been on one of them in England, that’s what I
was saying. I was on one of them. . . . I think that’d work,
yeah ’cos I think there is a . . . there is a lot of young
fellas want to give it up, but it’s just it’s in their face all
the time and that landing I was saying that I was on in
England every second day we were giving urines, every
second day, so they knew. I mean any tampering with the
urines or anything and that’s it you were gone. (IDUB10)
Respondents said that drug free units should employ strict
criteria and prisoners entering the unit should agree (in writ-
ing) to these criteria. Drug users wishing to enter should
first have adequate detoxification. Respondents also said
that random urine testing should be employed to monitor
participants’ drug status and those failing to observe the drug
free status should be removed from the unit.
Methadone maintenance
The majority of the respondents supported a well-regulated
methadone programme in all the Dublin prisons. Accord-
ing to the respondents, the positive aspects of a methadone
programme were that it prevents the spread of infection;
reduces or prevents injecting; facilitates withdrawing from
heroin; and had a stabilising effect in the prison:
Yeah, I think ((methadone maintenance)) would be a good,
I think that’d be a good way of getting an awful lot of
people that’s, that has prison habits if they started a main-
tenance instead of a quick detox because at the end of
the day when you come off detox you’re still ((suffering
from withdrawals and want heroin)) (IDUA7)
It is a good thing, from what I’ve seen on the main-
tenance . . . . I’ve seen a lot of people that’ve been on
the maintenance have cut down a lot on drugs because
if they’d have taken 60, 70 ml of physeptone well then
heroin’s no good to them any more, h’mm? I think they’re
just two drugs that just don’t go with each other, you
know? One drug cuts the other out like, I think, h’mm?
(NONB11)
I’d rather see them on that ((methadone)) than dying sick
you know. ’Cos I know what it’s like, it’s not nice . . . .
(NONB16)
A small number of injector and non-injector respondents
expressed mixed feelings. They said that methadone mainte-
nance would prevent persons having withdrawals and violent
incidences, but inmates may use both heroin and methadone,
or inmates may not opt for methadone as it does not have
the same ‘buzz’ as heroin. Some respondents reported that
withdrawals from methadone were more painful than with-
drawals from heroin.
One injector and five non-injectors would not support
a methadone maintenance programme in prison. These
respondents said that heroin users may use both or that
the prison authorities may use methadone as a ‘control
mechanism’.
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Well I can’t say I genuinely say anyone taking methadone
for the benefit, they use it and they use heroin you know
what I mean . . . . And I’ve been told by people that use
it that it’s harder to get off the methadone than it is the
heroin. (NONA9)
Like, they’re talking about bringing this maintenance
methadone course in and anybody that wants be on it,
you know? . . . But all that, all that’ll do, that’ll just keep
everybody stoned 24 h a day, every day. You know what I
mean?, so like they’re still giving drugs, you know what
I mean? They’re not, they’re not tackling the drug prob-
lem. They’ll be still going around stoned on methadone
every day. (IDUA8)
Needle exchange
There are no needle exchanges in Irish prisons and re-
spondents were divided on support for needle exchange in
prison. Seven injectors and five non-injectors would support
a needle exchange in prison while two injectors and four
non-injectors had mixed feelings. Equal numbers of injec-
tors (6) and non-injectors (6) would oppose needle exchange
in prison. Some respondents reported that the prison officers
would not allow needle exchange in prison.
. . . The drug problem is there, I think they should give out
clean needles. . . . Know what I mean? That’s my opinion.
That’s what they should do because you know the way
they’re sharing and all? an’ I’d say the best part of half
of that place up there has the virus . . . (IDUA11)
What would you think about giving them clean needles,
and syringes? (J.L.)
Ah, it’s probably a good idea cos there’s no point in saying
that it’s going to encourage them cos they’re going to do
it anyway, do’ya know what I mean, (NONA15)
Hmm. . . And do you think that that could be dangerous
for people who are injecting if there was a lot of clean
needles given out to prisoners, . . . say to people like your-
self? (J.L.)
No, cos if they’re going to do it they’d do it anyway, cos
they have needles there like, do’ya know what I mean,
they have needles there, there could be as much dirty
needles there already as you give them clean needles, you
know what I mean, so they have them there anyway like,
but ah, but I don’t think that’d be a risk. (NONA15)
There’s two sides to that coin, you know? . . . . I think it’d
stop a lot of the drugs, not a lot ((of drugs)), sorry, stop a
lot of AIDS spread, you know? Em, they shouldn’t have
drugs in prison, they shouldn’t have to need to hand out
needles, you know? . . . To prisoners, you know what I
mean? But the fact is the problem is there and like they’ll
have to do something. (IDUA10)
What would you think about it in prison? (J.L.)
Needle exchange? Oh Miss, Miss, Miss, Miss T’would
be bad, bad news. I would definitely now tell ya out,
like y’know wha I’mean I know they’d probably love it,
because I mean, getting needle exchange in prison, that
gives them the, a licence to inject. (NONA6)
A number of respondents said that needle exchange would
reduce the spread of infection in prison, but a significant
number of these feared that the needles could be used as
weapons in disputes with prison officers and other prisoners.
A small number thought that it would encourage even more
prisoners to start injecting in prison.
Why not?((there should be no needle exchange)) (J.L.)
Just . . . it’s for the officers safeties as well, you know
like?, in case an officer gets jabbed or anything, but just
for other reasons like, er, people, like who wear jewellery
and all, they’d take your jewellery and all off you, and
with a syringe as well if they were giving it out, you
know? It’d be . . . I think it’d be mad to give out syringes
in prison. (IDUB9)
I don’t know if it would work, em, from a safety point
of view, em, I think that they could be used as weapons
against the officers and they don’t even have to be used,
there’s always that fear that they might have been used.
(NONB4)
Discussion
This study presents, for the first time, prisoners’ views of
the extent of the drug problem in Dublin prisons and their
suggestions for interventions to address this issue. Their sug-
gestions indicate that prisoners could be an important re-
source when planning health services and that their needs
are realistic and humane. The study provides contextual data
illustrating how sharing is a risk factor in the Irish prison en-
vironment. In addition, the study also describes the move in
prison from smoking heroin to injecting. It is clear that these
practices (starting to inject, sharing injecting equipment fre-
quently with a larger cohort of individuals and inadequate
cleaning and sterilising of injecting equipment) increase the
likelihood of contracting HIV, hepatitis B and, in particu-
lar, hepatitis C in prison. The validity of the study findings
are indicated by the similarity of the findings to those from
other studies (Bird et al., 1992, 1995; Carvell & Hart, 1990;
Dillon, 2001; Dolan et al., 1996; Gore et al., 1995, 1997;
Malliori et al., 1998; Turnbull et al., 1991, 1994).
At the time the data presented in this paper was col-
lected, Dillon (2001) conducted an exploratory study ex-
amining drug use among prisoners (n = 29) in Mountjoy
Prison Complex, Dublin. Where there was topic overlap with
Dillon’s study (Dillon, 2001), the findings were similar. In
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both studies, respondents reported a similar history with re-
spect to drug use, and criminal activity and drug misuse were
interlinked. Whereas Dillon (2001) asked respondents about
their experience and perceptions of different harm reduction
interventions, the present study asked what the prison au-
thorities could do to address drug misuse. In both studies,
respondents described similar shortcomings of the current
service to address drug misuse in the prison environment.
It is timely for policy makers, researchers and clinicians
working in prisons to ensure that being in prison does not
add unnecessarily to the health risks of an already disad-
vantaged population. Community drug treatment services in
Ireland have evolved considerably over the last decade and
needle exchange and methadone maintenance are widely
available. The Irish prison health care system has not kept
pace with this change, but this is not unique, as few prison
health care services implement such measures (Dolan, Hall,
& Wodak, 1998; European Monitoring Centre for Drugs and
Drug Addiction, 2000; Farrell, Howes, Vester, & Davoli,
1999). The research available on Irish prisons (Allwright
et al., 2000; Dillon, 2001; Long et al., 2001; O’Mahony,
1997) suggests a need to consider provision of a broad
range of harm reduction measures in Irish prisons. Ster-
ilising tablets, needle exchange, methadone maintenance,
methadone detoxification and drug free units have been
presented as harm reduction methods that could be used in
prisons. However, prior to their introduction, the evidence
supporting the use of each of these harm reduction meth-
ods needs to be examined in the prison setting. There is
considerable evidence supporting methadone maintenance
(Marsch, 1998) and needle exchange (Goldberg, Cameron,
& McMenamin, 1998; Hurley, Jolley, & Kaldor, 1997;
Smyth, Keenan, & O’Connor, 1999) in community settings,
but only limited evidence of their effectiveness in prevent-
ing hepatitis C either in community settings or in the prison
environment (Darke, Kaye, & Finlay-Jones, 1998; Dolan
et al., 1996; Dolan, Wodak, Mattick, & Hall, 2000). Dolan
et al. (2000) observed a lower incidence of anti-HCV in
injectors randomly allocated to methadone maintenance in
an Australian prison than in injectors randomly allocated to
a methadone maintenance waiting list in the same prison.
Small-scale prison studies have shown that bleach and
needle exchange can reduce the spread of HIV in prisons
(Goldberg et al., 1998; Kent, 1996) but these have not been
evaluated for prevention of hepatitis C.
The findings resulting from the quantitative surveys linked
to this study (Allwright, Barry, Bradley, Long, & Thronton,
1999; Allwright et al., 2000; Long et al., 2000, 2001;
Thornton et al., 2000) appear to have been a catalyst for
dialogue at a national level (Smyth et al., 2000). As a re-
sult there has been agreement by the prison services that
a comprehensive and compassionate approach is required
to address the use of illicit heroin and its consequences in
the Irish prison setting. The Department of Justice, Equal-
ity and Law Reform has also recently instituted a Steering
Group on Prison Based Drug Treatment Services. This
Steering Group has outlined 10 intentions that underpin the
introduction of prison-based drug treatment services in Irish
prisons (Irish Prison Service, 2000). Importantly, the Steer-
ing Group noted that “the prison service must replicate in
prison, the level of medical and other supports available in
the community for drug-dependent people to the maximum
extent possible”. This is a formal statement of support for
the principle of equivalence of care with community drug
services also supported by this study.
At present, there is a drug services plan proposed for five
of the six Dublin prisons and an intention to approve a plan
for the remaining prison. These services include prevention,
detoxification, methadone maintenance, counselling and ed-
ucation. The intentions of the Steering Group for Prison
Based Drug Treatment Services are encouraging, although
the plan does not specify deadlines targets or budgets. As a
result of the plan, methadone maintenance has been intro-
duced in five Dublin prisons. Whereas by the end of January
2001, 24 prisoners were receiving methadone, by the end
of August 2002, 338 prisoners were receiving methadone
(Barry, personal communication). Given that on average,
there are 700 persons with a history of heroin misuse in
Dublin prisons on any single day, it is apparent that there is
still much to do.
As regards the cleaning and provision of injecting equip-
ment, there have been two attempts to introduce the formal
distribution of full strength household bleach in Irish prisons
but these have been rejected by the Prison Officers Associ-
ation because they fear an increase in attacks on prisoners
or prison officers. The provision of bleach tablet distribu-
tions in London prisons (Branigan, Hillsdon, & Wellings,
2000) and needle exchange interventions in other prisons
in Europe (Dolan, Rutter, & Wodak, 2003; Nelles, Fuhrer,
Hirsbruhher, & Harding, 1998) has not led to an increase in
attacks on prisoners or prison officers.
Conclusion
Substance misuse is an underlying problem for a large
proportion of prisoners in the Republic of Ireland. There is
a need to pilot harm minimisation interventions in Irish pris-
ons, to examine their strengths and weaknesses in the Irish
setting and to measure their effects, particularly in relation
to the transmission of blood-borne viruses. It is important to
note that the vast majority of prisoners view time in prison
as an opportunity to address problems associated with sub-
stance misuse and that health professionals should not miss
this opportunity.
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